89 FR 74 pg. 26926 - Notice Pursuant to the National Cooperative Research and Production Act of 1993—Subcutaneous Drug Development & Delivery Consortium, Inc.
Type: NOTICEVolume: 89Number: 74Page: 26926
Page: 26926FR document: [FR Doc. 2024-07988 Filed 4-15-24; 8:45 am]
Agency: Justice Department
Sub Agency: Antitrust Division
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Subcutaneous Drug Development & Delivery Consortium, Inc.
Notice is hereby given that on February 2, 2024, pursuant to section 6(a) of the Act of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. ("the Act"), Subcutaneous Drug Development & Delivery Consortium, Inc. ("SC Consortium") has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Eli Lilly and Company, Indianapolis, IN; and Kaléo, Inc., Richmond, VA, have withdrawn as parties to this venture.
No other changes have been made in the membership or the planned activity of the group research project. Membership in this group research project remains open and Subcutaneous Drug Development & Delivery Consortium, Inc. intends to file additional written notifications disclosing all changes in membership.
On October 26, 2020, Subcutaneous Drug Development & Delivery Consortium, Inc. filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on December 3, 2020 (85 FR 78148).
The last notification was filed with the Department on June 23, 2023. A notice was published in the Federal Register pursuant to section 6(b) of the Act on August 23, 2023 (88 FR 57479).
Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-07988 Filed 4-15-24; 8:45 am]
BILLING CODE P